1bqi

From Proteopedia
Revision as of 12:43, 20 November 2007 by OCA (talk | contribs) (New page: left|200px<br /><applet load="1bqi" size="450" color="white" frame="true" align="right" spinBox="true" caption="1bqi, resolution 2.5Å" /> '''USE OF PAPAIN AS A MO...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
File:1bqi.gif


1bqi, resolution 2.5Å

Drag the structure with the mouse to rotate

USE OF PAPAIN AS A MODEL FOR THE STRUCTURE-BASED DESIGN OF CATHEPSIN K INHIBITORS. CRYSTAL STRUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES.

OverviewOverview

Papain has been used as a surrogate enzyme in a drug design effort to, obtain potent and selective inhibitors of cathepsin K, a new member of the, papain superfamily of cysteine proteases that is selectively and highly, expressed in osteoclasts and is implicated in bone resorption. Here we, report the crystal structures of two papain-inhibitor complexes and the, rational design of novel cathepsin K inhibitors. Unlike previously known, crystal structures of papain-inhibitor complexes, our papain structures, show ligand binding extending deep within the S'-subsites. The two, inhibitor complexes, carbobenzyloxyleucinyl-leucinyl-leucinal and, carbobenzyloxy-L-leucinyl-L-leucinyl methoxymethyl ketone, were refined to, 2.2- and 2.5-A resolution with R-factors of 0.190 and 0. 217, respectively. The S'-subsite interactions with the inhibitors are, dominated by an aromatic-aromatic stacking and an oxygen-aromatic ring, edge interaction. The knowledge of S'-subsite interactions led to a design, strategy for an inhibitor spanning both subsites and yielded a novel, symmetric inhibitor selective for cathepsin K. Simultaneous exploitation, of both S- and S'-sites provides a general strategy for the design of, cysteine protease inhibitors having high specificity to their target, enzymes.

About this StructureAbout this Structure

1BQI is a Single protein structure of sequence from Carica papaya with SBA as ligand. Full crystallographic information is available from OCA.

ReferenceReference

Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites., LaLonde JM, Zhao B, Smith WW, Janson CA, DesJarlais RL, Tomaszek TA, Carr TJ, Thompson SK, Oh HJ, Yamashita DS, Veber DF, Abdel-Meguid SS, J Med Chem. 1998 Nov 5;41(23):4567-76. PMID:9804696

Page seeded by OCA on Tue Nov 20 11:50:26 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA